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Article focus
  Numerous models, both generic and hip 
fracture-specific, have been developed to 
predict mortality after hip fracture surgery.
  the Nottingham Hip Fracture Score has 
been validated and applied widely in the 
United Kingdom for predicting mortality 
in hip fracture patients.
  the refined risk adjustment model used 
by the National Hip Fracture Database 
was compared with the Nottingham Hip 
Fracture Score using national clinical 
audit data.
Key messages
  the model used by the National Hip 
Fracture Database performed as well as 
the Nottingham Hip Fracture Score.
  the National Hip Fracture Database 
model is a suitable alternative to the 
Nottingham Hip Fracture Score for risk 
adjustment in the United Kingdom hip 
fracture population.
Strengths and limitations
  patients who had any type of surgery for 
hip fracture were included in the study, 
predicting 30-day mortality after hip 
fracture surgery 
evalUatioN oF tHe NatioNal Hip FractUre DatabaSe caSe-mix 
aDJUStmeNt moDel
Objectives
The national Hip Fracture Database (nHFD) publishes hospital-level risk-adjusted mortality 
rates following hip fracture surgery in england, Wales and northern Ireland. The perfor-
mance of the risk model used by the nHFD was compared with the widely-used nottingham 
Hip Fracture score.
Methods
Data from 94 hospitals on patients aged 60 to 110 who had hip fracture surgery between 
May 2013 and July 2013 were analysed. Data were linked to the office for national statis-
tics (ons) death register to calculate the 30-day mortality rate. Risk of death was predicted 
for each patient using the nHFD and nottingham models in a development dataset using 
logistic regression to define the models’ coefficients. This was followed by testing the per-
formance of these refined models in a second validation dataset.
Results
The 30-day mortality rate was 5.36% in the validation dataset (n = 3861), slightly lower 
than the 6.40% in the development dataset (n = 4044). The nHFD and nottingham models 
showed a slightly lower discrimination in the validation dataset compared with the develop-
ment dataset, but both still displayed moderate discriminative power (c-statistic for nHFD = 
0.71, 95% confidence interval (cI) 0.67 to 0.74; nottingham model = 0.70, 95% cI 0.68 to 
0.75). Both models defined similar ranges of predicted mortality risk (1% to 18%) in assess-
ment of calibration.
Conclusions
Both models have limitations in predicting mortality for individual patients after hip frac-
ture surgery, but the nHFD risk adjustment model performed as well as the widely-used 
 nottingham prognostic tool and is therefore a reasonable alternative for risk adjustment in 
the United Kingdom hip fracture population.
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and thus the findings are applicable to the entire hip 
fracture population.
  Data quality in this study was better than in earlier 
validation studies of the Nottingham model, and 
missing data were managed using the robust 
approach of multiple imputation.
  there may be residual confounding due to risk factors 
that were not, or were only partly, captured in the 
dataset.
introduction
over 65 000 people aged 60 years or older suffer a hip 
fracture in england, Wales and Northern ireland every 
year.1 the injury is associated with increased risk of death, 
with only approximately 70% of patients surviving one 
year after their fracture, and 7% of patients dying within 
30 days of admission (4622/64 858).1 Numerous patient 
factors are associated with mortality after hip fracture. it 
is important that such case-mix variation is considered in 
the analysis and interpretation of hospital-level results in 
national clinical audits, not least when this information is 
used to benchmark services.
the National Hip Fracture Database (NHFD) has been 
publishing information on patient outcomes following 
hip fracture in england, Wales and Northern ireland since 
2007. Hospital figures for 30-day mortality rates have 
always been risk-adjusted by the NHFD, with periodic 
review of evidence on prognostic models for hip fracture 
patients to support improvement of its risk adjustment 
method. this latest refinement to the NHFD risk adjust-
ment model was first implemented in 2014.2 the NHFD 
model features the same six patient factors as the model 
developed by Holt et al3 from the Scottish Hip Fracture 
audit, although different categories are used for some 
variables.
prognostic tools specific to patients with hip fracture 
are unsurprisingly more reliable than generic models,4,5 
but their performances are affected by characteristics of 
the populations from which they were derived. Different 
models incorporate a variety of patient characteristics,3-7 
but it is not always clear whether the additional burden of 
data collection for more complex models is justified by 
enhanced predictive performance.
the Nottingham Hip Fracture Score is one of the most 
frequently used and extensively validated outcome pre-
diction models for hip fracture patients.6-8 it was devel-
oped in an english hospital setting and, in 2014, over half 
(51.7%) of hospitals in england, Wales and Northern 
ireland (93/180) reported occasional or routine use of 
this tool.9 it has been validated in the United Kingdom 
and elsewhere against generic models for post-operative 
mortality such as the Surgical outcome risk tool (Sort) 
and hip-specific models such as the almelo Hip Fracture 
Score (aHFS).6,8,10-12 it has been recalibrated since its ini-
tial development and the creators have recommended 
further adjustments to account for changes in the hip 
fracture population.8 in this study, the risk model used by 
the NHFD for 30-day mortality2,9,13 was evaluated by 
comparing its performance against the Nottingham 
model.
patients and Methods
Data sources. the study used data collected by the NHFD 
as part of the royal college of physicians and association 
of anaesthetists of great britain and ireland collaborative 
‘sprint’ audit on anaesthetic practice. the anaesthetic 
Sprint audit of practice (aSap) ran in parallel with stan-
dard NHFD data collection over three months in 2013 at 
95 hospitals in england, Wales and Northern ireland.14 
During this time, hospitals submitted data on addi-
tional audit fields beyond the standard NHFD dataset, 
which enabled the estimation of individual patients’ risk 
of 30-day mortality using both NHFD and Nottingham 
models.
ethical approval was not required since the NHFD has 
Section 251 approval from the Health research authority’s 
confidentiality advisory group to collect details of hip 
fracture patients and link their data with the office for 
National Statistics (oNS) death register.
patient population. the study included patients who 
were admitted for hip fracture, between 1 may 2013 
and 31 July 2013, to a NHS hospital in england, Wales 
or Northern ireland that participated in aSap. patients 
with known operation type were selected for analysis if 
they were aged between 60 and 110 years, so long as 
their mortality status at 30 days after surgery could be 
confirmed by linking their record with the oNS death 
register.
The risk models. the NHFD model contains six variables:2 
age; gender; american Society of anesthesiologists (aSa) 
physical status grade; ability to walk indoors; fracture 
type; and source of admission. the Nottingham model 
contains seven variables: age; gender; number of comor-
bidities; abbreviated mental test score on admission; 
haemoglobin concentration; living in an institution; and 
malignant disease. the Nottingham model was devel-
oped with age stratified into three categories (< 66, 66 to 
85, and ⩾ 86 years). this study however used the slightly 
different categories that were applied in the aSap study.7 
these corresponded to the categories used in the NHFD 
model. there was also some overlap between the two 
models in the other patient risk factors that they contain 
(table i).
Statistical analysis. We used a standard approach for 
assessing and improving prediction models15 whereby a 
model is refined in one dataset before its performance is 
examined in a different group of patients.
We used a ‘development’ dataset of patients admitted 
between 1 may 2013 and 15 June 2013 to recalculate 
(recalibrate) the coefficients of the risk factors in the NHFD 
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and Nottingham models. each patient’s probability of 
death within 30 days of surgery for hip fracture could 
then be predicted from the regression coefficients of the 
two models.16,17
the resulting risk equations for the two models were 
applied to the ‘validation’ dataset of patients admitted 
between 16 June 2013 and 31 July 2013 to examine their 
predicted risk of death.16,17
the ‘discrimination’ of a model describes its ability to 
differentiate between patients who survived or died using 
the area under the receiver-operating characteristic (roc) 
curve. We interpreted values of this ‘c-statistic’ as indicat-
ing poor model performance if they were below 0.70, as 
moderate for 0.70 to 0.79, and as good performance for 
0.80 to 0.89.12,18
the ‘calibration’ of a model compares the predicted 
and observed mortality rates between groups of patients 
who are grouped based on their predicted mortality risk. 
We assessed calibration visually and with the Hosmer-
lemeshow test, with patients allocated to eight predicted 
risk groups. goodness of fit was considered adequate if 
the p-value was less than 0.05.19
We addressed missing data using multiple imputation 
by chained equations (mice), that is, missing data 
assumed to be missing at random. rubin’s rules were 
applied to produce 20 imputed datasets.20 all analyses 
were carried out using Stata version 14.1 (Statacorp lp, 
college Station, texas).
Results
During the study period, 8290 patients with hip fracture 
presented to hospitals that participated in aSap. the fol-
lowing exclusions were made: n = 116 missing the date 
of operation; n = 96 missing the type of operation; 
n =  172 where survival after operation was unknown; 
and n = 1 with missing data for six risk factors. after 
exclusions, 7905 patients from 94 hospitals were included 
in the analysis (Fig. 1).
the distribution of patient factors was relatively similar 
in the development and validation datasets (table ii). the 
overall mortality rate was 5.89% (466/7905). the mortal-
ity rate within 30 days of surgery for hip fracture was 
6.40% in the development dataset (259/4044), but was 
slightly lower at 5.36% in the validation dataset (207/3861).
Table i. patient factors in the Nottingham and National Hip Fracture Database (NHFD) models
patient factor in NHFD NHFD categories in Nottingham model Nottingham categories
age (yrs) yes yes  
 60 to 69 60 to 69
 70 to 79 70 to 79
 80 to 89 80 to 89
 90 to 110 90 to 110
gender yes yes  
 male male
 Female Female
Source of admission yes N/a  
 own home/sheltered housing  
 Not from own home  
aSa grade yes N/a  
 1 or 2  
 3  
 4 or 5  
Walking indoors ability yes N/a  
 regularly walked without aids  
 regularly walked with one aid, two aids or frame  
 Wheelchair or bedbound  
Fracture type yes N/a  
 intracapsular  
 extracapsular (or other)  
Number of comorbidities N/a yes  
 0 to 1
 ⩾ 2
amtS on admission N/a yes  
 Number from 0 to 10
Hb on admission N/a yes  
 Numeric value
living in an institution N/a yes  
 yes
 No
malignant disease N/a yes  
 yes
 No
aSa, american Society of anesthesiologists; amtS, abbreviated mental test Score; Hb, Haemoglobin concentration; NHFD, National Hip Fracture Database; 
N/a, Not applicable
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Hip fracture patients admitted to hospitals 
participating in ASAP between 01 May and 
31 July 2013, n = 8290 
Exclusions, n = 385 
n = 116 missing the date of hip fracture surgery 
n = 96 missing type of operation 
n = 172 missing post-operative mortality status 
n = 1 missing data for six risk factors 
Patients included in analyses, n = 7905 
Fig. 1
Flow diagram of study participation. aSap, anaesthesia Sprint audit of practice.
Table ii. patient factors and 30-day mortality rate in development and validation datasets
Full dataset Development set, n = 4044 Validation set, n = 3861
All patients Died All patients Died All patients Died
patient factor n % % n % % n % %
Age (yrs)  
60 to 69 711 9.0 3.1 373 9.2 2.9 338 8.8 3.3
70 to 79 1780 22.5 4.0 871 21.5 4.8 909 23.5 3.2
80 to 89 3673 46.5 5.6 1906 47.1 5.9 1767 45.8 5.3
90 to 110 1741 22.0 9.6 894 22.1 10.5 847 21.9 8.6
Gender  
Female 5719 72.3 4.6 2940 72.7 4.7 2779 72.0 4.5
male 2186 27.7 9.3 1104 27.3 10.9 1082 28.0 7.7
Source of admission  
own home/sheltered housing 5996 75.9 4.9 3065 75.8 5.3 2931 75.9 4.4
Not from own home 1909 24.1 9.1 979 24.2 9.8 930 24.1 8.4
ASA grade  
1 or 2 2482 31.4 1.8 1246 30.8 1.8 1236 32.0 1.8
3 4264 53.9 6.5 2197 54.3 7.0 2067 53.5 6.0
4 or 5 954 12.1 13.8 488 12.1 15.6 466 12.1 12.0
Unknown/missing 205 2.6 5.4 113 2.8 6.2 89 2.3 4.3
Walking indoors ability  
Without aids 3784 47.9 4.0 1926 47.6 4 1858 48.1 4.0
one aid, two aids or frame, wheelchair or bedbound 4003 50.6 7.5 2055 50.8 8.4 1948 50.5 6.5
Unknown/missing 118 1.5 11.9 63 1.6 12.7 55 1.4 10.9
Fracture type  
intracapsular 4563 57.7 6.1 2315 57.2 6.5) 2248 58.2 5.7
extracapsular, including other 3342 42.3 5.6 1729 42.8 6.3 1613 41.8 4.8
Comorbidities  
0 to 1 3495 44.2 3.8 1807 44.7 3.7 1688 43.7 4.0
⩾ 2 3222 40.8 7.7 1744 43.1 8.3 1478 38.3 6.9
missing 1188 15.0 7.2 493 12.2 9.5 695 18.0 5.5
AMTS on admission  
0 to 6 2330 29.5 8.9 1219 30.1 9.4 1111 28.8 8.5
7 to 10 5047 63.8 4.0 2552 63.1 4.6 2495 64.6 3.4
Unknown/missing 528 6.7 10.4 273 6.8 5.3 221 5.7 11.3
Hb on admission  
> 10 g/dl-1 7354 93 5.5 3732 92.3 5.9 3622 93.8 5.2
⩽ 10 g/dl-1 551 7.0 10.7 312 7.7 12.8 239 6.2 7.9
Living in an institution  
No 5996 75.9 4.9 3065 75.8 5.3 2931 75.9 4.4
yes 1909 24.1 9.1 979 24.2 9.8 930 24.1 8.4
Malignant disease  
No 7134 90.2 5.4 3638 90 5.9 3496 90.5 5.0
yes 771 9.8 10.2 406 10 11.3 365 9.5 9.0
aSa, american Society of anesthesiologists; amtS, abbreviated mental test score; Hb, Haemoglobin concentration
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Model recalibration and validation. the development 
dataset was used to derive coefficients for the NHFD and 
Nottingham models and produce the following risk scores:
NHFD risk score = exp (- 4.723 + (0.435 x age 70 to 
79) + (0.518 x age 80 to 89) + (1.060 x age 90 to 110) 
+ (0.894 x male) + (-0.275 x not admitted from home) 
+ (1.164 x aSa 3) + (1.933 x aSa 4 or 5) + (0.358 x walk 
with at least one aid) + (-0.055 x extracapsular 
fracture)).
Nottingham risk score = exp (- 3.955 + (- 0.407 x age 
70 to 79) + (0.485 x age 80 to 89) + (1.083 x age 90 to 
110) + (0.883 x male) + (0.558 x Hb ⩽ 10 g dl−1) + 
(0.662 x cancer) + (- 0.537 x amtS ⩾ 7) + (0.263 x living 
in institution) + (0.755 x ⩾ 2 comorbidities)).
the NHFD and Nottingham models displayed similar 
levels of performance (table iii). both were moderately 
able to distinguish between patients at high and low risk 
of death within 30 days, with a c-statistic of 0.71 for the 
NHFD model and 0.70 for the Nottingham model in the 
validation dataset.
model calibration was similar in both models, with a 
slightly reduced range of predicted risk in the validation 
dataset (Fig. 2). the Nottingham model displayed a bet-
ter fit (p-value = 0.599 for Hosmer-lemeshow test) than 
the NHFD model (p-value = 0.029), but both were incon-
sistent in their estimations of mortality risk for patients in 
the eight risk groups (Fig. 2).
Discussion
Main findings. case-mix adjustment is important in the 
development and refinement of prediction models, as 
potential confounding caused by differences in the pop-
ulations of individual hospitals must be addressed. the 
risk model used by the NHFD to adjust 30-day mortality 
rates for individual hospitals features the same six patient 
factors as previous NHFD risk models, but with different 
categories for some variables, and is based on a regres-
sion equation rather than a classification tree.21
in this evaluation of the NHFD risk model, its perfor-
mance was comparable with one of the most commonly 
used and well validated outcome prediction tools for hip 
fracture – the Nottingham Hip Fracture Score. both mod-
els displayed moderate discriminative power, with the 
NHFD model achieving a slightly higher c-statistic of 0.71 
in the validation dataset. the two models also displayed 
moderate levels of calibration, although there was some 
inconsistent estimation of mortality risk for patients in dif-
ferent risk groups when applied to the validation dataset. 
these findings are consistent with studies that have found 
limited goodness of fit for the Nottingham model and the 
model described by Holt et al.5,10
Strengths and limitations. previous studies have excluded 
certain patient groups, such as those who underwent 
total hip arthroplasty,5 but this study included patients 
who had any type of surgery for hip fracture. the find-
ings could therefore be applied to the whole hip frac-
ture population. the study has several other strengths. 
it used better quality data than earlier validation studies 
of the Nottingham model because a high level of data 
completeness was achieved in the aSap, where hospitals 
were excluded if their case ascertainment was 80% or 
less. We adopted the more robust approach of multiple 
imputation to manage missing data,22 while other valida-
tion studies limited themselves to complete case analysis 
by excluding records with missing data.6,10
validation of the Nottingham model using the original 
and subsequently recalibrated risk score was not feasible 
as the regression coefficients used to calculate the current 
Nottingham Hip Fracture Score are not publicly availa-
ble.8 comorbidities were only recorded in the aSap data-
set in terms of whether they were present or not, so it 
was not possible to determine whether patients without 
specific recorded comorbidities truly did not have those 
conditions.
Finally, both models include a selection of patient 
characteristics associated with death following surgery 
for hip fracture,23 but they do not capture all potential 
factors of interest. Future refinement of either model 
should be guided by the availability and reliability of 
recorded variables.
implications for further research and clinical prac-
tice. this study has demonstrated that the NHFD model 
performs comparably with the Nottingham model, and 
meets current standards for hip fracture outcome pre-
diction in the United Kingdom hip fracture population. 
therefore, the NHFD model could be considered for 
use as an alternative to the Nottingham model, espe-
cially if variables (such as haemoglobin concentration 
or the nature and number of comorbidities) are poorly 
recorded or missing.
Table iii. performance of Nottingham and NHFD models
Dataset Model patients, n Hosmer-Lemeshow test Area under ROC curve
 chi-squared df p-value C-statistic 95% Ci
Development Nottingham 4044 6.27 6 0.394 0.73 0.70 to 0.76
 NHFD 4044 11.3 5 0.078 0.74 0.71 to 0.77
validation Nottingham 3861 6.10 6 0.599 0.70 0.67 to 0.74
 NHFD 3861 14.9 5 0.029 0.71 0.68 to 0.75
ci, confidence intervals; df, degrees of freedom; NHFD, National Hip Fracture Database; Nottingham, Nottingham Hip Fracture Score; roc, receiver operating 
characteristic
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there is room for improvement in both models. When 
used to calculate risk-adjusted outcomes of hospitals, 
there is a small chance of wrongly classifying a hospital as 
an outlier. However, compared with making predictions 
for individual patients, the size of the error will be small. 
this is because the risk adjustment process aims to esti-
mate the average risk of all patients treated at different 
hospitals, and the differences in the average risks among 
hospitals is much less than the differences in the risks 
among individual patients.
if these models are to be used to predict mortality at 
the individual patient level, we suggest that they be fur-
ther refined and validated. For example, regular recali-
bration of both models is appropriate given the trend in 
decreasing 30-day mortality rate over recent years 
(7.1% in 2015 compared with 8.0% in 2013).1,13 
Similarly, changes to the profile of hip fracture patients 
will need to be taken into account in future updates to 
the models.24 However, the risk of death faced by an 
individual patient cannot be fully defined by any model 
based on risk factors present on admission, since it will 
obviously also depend on the quality of care they sub-
sequently receive. the importance of prompt surgery 
and peri-operative orthogeriatric assessment are just 
two examples of aspects of care that impact on patients’ 
mortality risk.
While mortality is the most commonly measured 
patient outcome, there are many other outcomes rele-
vant to the assessment of care delivered to hip fracture 
patients. For example, functional independence and 
quality of life in the intermediate future following hip 
fracture are of interest and importance to patients and 
their families, care providers and policy makers. Future 
studies would benefit from assessing the performances of 
these tools in their ability to predict differences among 
patients on these outcomes. this would lead to a better 
understanding of how different patient groups (such as 
those at relatively high risk or low risk of death within 
30  days of surgery) are affected by hip fracture in the 
months after completing hospital treatment.
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Fig. 2b
observed versus predicted 30-day mortality by risk group, Nottingham and National Hip Fracture Database (NHFD) models. Figure 2a) shows the development 
dataset, while b) shows the validation dataset.
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